National Brain Tumor Society Walk/Run ~ Sunday, October 2nd
Irish Chamber members and friends are invited to join the McLaughlin team, “Jimmy Mack Pack”
Click HERE to sponsor Jimmy Mack Pack team, or to join.
Welcome new Irish Chamber members! Be sure to look out for new members at upcoming events. They will have maroon ribbons on their name tags.
Individual Members
– William Murphy, TriState Capital Bank
– Daniel McGuire, HP
– Michael DuFrayne, EisnerAmper
– Matthew Holden, The Graham Company
– Thomas Horan, Shaw Fishman Glantz & Towbin LLC
– Alexander Farley, American Insurance Management
– Madeline Sherry, Esq., Gibbons P.C.
– Frank McGee, The McGee Group LLC
– Joseph E. Vaughan, Esq., O’Hagan LLC
– Kathy Bellwoar, PPT Consulting LLC
– Ed Waters, Island Networks, Inc.
– Carl Cherkin, The Philadelphia Union
– John Branka, Standard Digital Imaging
– Tracy Gilvarry, Esq., Investment Fund & Financial Services Lawyer
– Kathleen McGarvey, Firstrust Bank
– Lori Greenawalt, Access Earth
– Chris Lawlor, Learn International
– Mike Riley, EthoSource, LLC
– Sean Kennedy, SK Strategies
Mid-Size Firm Members
– StreamLine Payroll, LLC, Brian Tierney and Patty Duffy
– PA Department of Community & Economic Development, Joseph Burke and Michael O’Rourke
– Boyle Financial Associates, Gerard Boyle and James Boyle
– GREYHAWK, Ron Kerins and Jay Appleton
– Merrill Lynch Global Wealth Management, Bob Sullivan and Pierre Chéry
Large Corporate Members
– Aer Lingus, Jeff Wright
– American Ireland Fund, Patrick Tully
– SmartInvest, Gerry Moan
FOR IMMEDIATE RELEASE: HPT Pharma, LLC Acquisition of Elmark Packaging, Inc. and Brandywine Labels, Inc. Means Across the Board Win for Customers
HPT Pharma, LLC Acquisition of Elmark Packaging, Inc. and Brandywine Labels, Inc. Means Across the Board Win for Customers
Warrington, PA – August 3, 2016: HPT Pharma President JM Hasson announced today that the company has completed its acquisition of Elmark Packaging, Inc. and Brandywine Labels, Inc.
HPT’s strategic and simultaneous acquisition will help expand its portfolio of innovative, customer-centric packaging solutions deeper into pharma, food, consumer product, chemical, and other markets.
“Our newly expanded customer base can look forward to an enhanced supply chain partner that is better equipped to service their needs, “said Hasson. “Bringing Elmark and Brandywine into the HPT family means we can offer them the secondary and tertiary packaging solutions that will make us a critical link in their value chain.”
|
|
|
| Craigavon, N.I., UK, – 2 August 2016 – Almac Group, the global contract development and manufacturing organisation, wishes to congratulate its long-term client partner, Amicus Therapeutics on the European approval of its first orphan drug product and precision medicine Galafold™ (migalastat, also referred to as AT1001). Galafold was approved as a first line therapy for long-term treatment of adults and adolescents (aged 16 years and older) with a confirmed diagnosis of Fabry disease (alpha-galactosidase A deficiency) and who have an amenable mutation. |
IABCN Board Members with Ambassador Anne Anderson, Consul General Barbara Jones, Tánaiste Frances Fitzgerald and Chairman of the Board of The Rosenbach Museum & Library, Arthur Spector.
(front row, left to right) Ambassador Anderson, Consul General Barbara Jones, Christine Hartmann, Tánaiste Fitzgerald and Kevin Kent
(front row) Arthur Spector and Siobhan Reardon
(back row) Sean Flatley and Bill McLaughlin
Click below to view more photos from our welcoming reception at The Rosenbach on July 25, 2016.
ICON has announced financial results for the second quarter 2016. Please find details below. Full consolidated income statements and summary balance sheet data can be read here.
Some highlights from the quarter include:
• ICON’s acquisition of ClinicalRM which has extended ICON’s presence in the market for government-funded research and has enhanced ICON’s capabilities in vaccines and infectious disease. At the height of the Ebola crisis, ClinicalRM worked on several clinical trials in West Africa and the company is currently supporting the Zika Emergency Response plan.
• A renewal of ICON’s service agreement with Pfizer, where ICON will continue to provide expertise in the planning, execution and management of Pfizer’s clinical trials. ICON first entered into a strategic partnership with Pfizer in 2011.
